Autoimmune encephalitis associated with NMDA receptor antibodies: specific aspects of providing medical care to the patients in the intensive care and neurology departments of a multidisciplinary hospital. Report 1

Autoimmune encephalitis (AE) is a severe but potentially curable disease of the central nervous system. One of the main representatives of AE is anti-NMDA receptor AE (autoimmune encephalitis with antibodies to NMDAtype glutamate receptors). The disease is characterized by polymorphic symptoms (neuropsychiatric disorders, dyskinesia, autonomic dysfunction), rapid progression with the development of life-threatening conditions requiring treatment in the intensive care unit (ICU) and a multidisciplinary approach in a multidisciplinary hospital. This article presents the results of our own clinical observations of the diagnosis and treatment of patients with anti-NMDA receptor AE who were urgently hospitalized in the intensive care unit and the neurology department of a multidisciplinary medical institution (State Institution «432 Order of the Red Star main military Clinical Medical Center of the Armed Forces of the Republic of Belarus») with a discussion of diagnostic features, intensive care, and the most significant aspects of pathogenetic and symptomatic treatment.